Search Results - "Zeissig, S."

Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease by Zeissig, S, Bürgel, N, Günzel, D, Richter, J, Mankertz, J, Wahnschaffe, U, Kroesen, A J, Zeitz, M, Fromm, M, Schulzke, J-D

“…Background: Epithelial barrier function is impaired in Crohn’s disease. Aim: To define the underlying cellular mechanisms with special attention to tight…”
Get full text

Survival with nonmelanoma skin cancer in Germany by Eisemann, N., Jansen, L., Castro, F.A., Chen, T., Eberle, A., Nennecke, A., Zeissig, S.R., Brenner, H., Katalinic, A.

“…Summary Background Nonmelanoma skin cancer (NMSC) is the most common cancer in Germany, but detailed information on survival is lacking. Objectives To provide…”
Get full text

Tailored instructor feedback leads to more effective virtual-reality laparoscopic training by Paschold, M., Huber, T., Zeißig, S. R., Lang, H., Kneist, Werner

“…Background Laparoscopic novices begin at different performance levels, and studies on tailored training concepts are warranted. The effect of verbal instructor…”
Get full text

Occupation and cancer of the larynx: a systematic review and meta-analysis by Bayer, O., Cámara, R., Zeissig, S. R., Ressing, M., Dietz, A., Locati, L. D., Ramroth, H., Singer, S.

“…The aim of the study was to explore the relationship between occupational exposure, defined by occupational categories and job title, and laryngeal cancer. A…”
Get full text

Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor α antibody treatment by Zeissig, S, Bojarski, C, Buergel, N, Mankertz, J, Zeitz, M, Fromm, M, Schulzke, J D

“…Background and aims: Barrier dysfunction is an important feature contributing to inflammation and diarrhoea in Crohn’s disease (CD). Recently, tumour necrosis…”
Get full text

Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact by Zeissig, S R, Weyer-Elberich, V, Emrich, K, Binder, H, Fischbeck, S, Imruck, B H, Friedrich-Mai, P, Beutel, M E, Blettner, M

“…There are detailed reviews about different recruitment strategies, but not with regard to differences between recruitment of hospital-based versus office-based…”
Get full text

Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy by Ellrichmann, M, Bethge, J, Boesenkoetter, J, Conrad, C, Noth, R, Bahmer, T, Nikolaus, S, Aden, K, Zeissig, S, Schreiber, S

“…Abstract Objective Increased mortality from respiratory diseases was observed in epidemiological studies of patients with ulcerative colitis [UC] as a…”
Get full text

Laparoscopic assistance by operating room nurses: Results of a virtual-reality study by Paschold, M., Huber, T., Maedge, S., Zeissig, S.R., Lang, H., Kneist, W.

“…Laparoscopic assistance is often entrusted to a less experienced resident, medical student, or operating room nurse. Data regarding laparoscopic training for…”
Get full text

Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study by Hager, B, Kraywinkel, K, Keck, B, Katalinic, A, Meyer, M, Zeissig, S R, Scheufele, R, Wirth, M P, Huber, J

“…Background: Current guidelines do not recommend a preferred treatment modality for locally advanced prostate cancer. The aim of the study was to compare…”
Get full text

c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells by Geismann, C, Grohmann, F, Sebens, S, Wirths, G, Dreher, A, Häsler, R, Rosenstiel, P, Hauser, C, Egberts, J-H, Trauzold, A, Schneider, G, Sipos, B, Zeissig, S, Schreiber, S, Schäfer, H, Arlt, A

“…Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies with an overall life expectancy of 6 months despite current therapies. NF-…”
Get full text

c-Rel is a critical mediator of NF-[kappa]B-dependent TRAIL resistance of pancreatic cancer cells by Geismann, C, Grohmann, F, Sebens, S, Wirths, G, Dreher, A, Häsler, R, Rosenstiel, P, Hauser, C, Egberts, J-h, Trauzold, A, Schneider, G, Sipos, B, Zeissig, S, Schreiber, S, Schäfer, H, Arlt, A

“…Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies with an overall life expectancy of 6 months despite current therapies…”
Get full text

P1190 : The role of NKT cells in a mouse model (NOD.C3C4) with spontaneous bile duct inflammation by Schrumpf, E, Jiang, X, Zeissig, S, Pollheimer, M.J, Anmarkrud, J.A, Tan, C, Exley, M.A, Karlsen, T.H, Blumberg, R.S, Melum, E

Get full text

Sequencing-based hematopoietic miRNA landscape reveals common and distinct features of autoimmune inflammatory phenotypes by Juzenas, S., Hübenthal, M., Zeissig, S., Strüning, N., Keller, A., Schulte, D., D'Amato, M., Lindqvist, Carl Mårten, Kupcinskas, J., Schreiber, S., Halfvarson, Jonas, Hemmrich-Stanisak, G., Franke, A.

“…Background : MiRNAs represent a class of small non-coding RNAs which are involved in regulation of protein-coding gene expression. Being implicated in various…”
Get full text

P354 CHOLANGIOCYTES FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS EXPRESS CD1D AND HUMAN CHOLANGIOCYTES PRESENT ANTIGENS TO NATURAL KILLER T CELLS by Schrumpf, E, Tan, C, Karlsen, T.H, Sponheim, J, Jefferson, D.M, Zeissig, S, Exley, M.A, Blumberg, R.S, Melum, E

Get full text

Changes in Incidence and Mortality Trends of Head and Neck Cancer in Rhineland-Palatinate, 2000-2009 by Bayer, O, Krüger, M, Koutsimpelas, D, Emrich, K, Ressing, M, Zeissig, S R, Simon, C, Singer, S

“…Epidemiological data on HNC are often reported aggregated despite their anatomical and histological heterogeneity. In Germany, few studies have analyzed…”
Get more information

Rising incidence of papillary thyroid carcinoma in Germany by Radespiel-Tröger, M, Batzler, W U, Holleczek, B, Luttmann, S, Pritzkuleit, R, Stabenow, R, Urbschat, I, Zeissig, S R, Meyer, M

“…The incidence of thyroid cancer (TC), a rare malignancy, has strongly risen in recent decades. Possible causes of this rise include increasing diagnostic…”
Get full text

Neue Rubrik Epidemiologie by Zeissig, S. R., Arndt, V., Kraywinkel, K.

Get full text

Biosimilars in inflammatory bowel disease by Siegmund, B, Atreya, R, Bokemeyer, B, Kruis, W, Mudter, J, Sander, C, Schreiber, S, Reindl, W, Zeissig, S, Kucharzik, T

“…After the expiry date of the patent protection for Infliximab in 2013, the biosimilar CT‑P13 was approved for indications in Crohn's disease and ulcerative…”
Get more information

Inflammatory bowel disease by Kaser, Arthur, Zeissig, Sebastian, Blumberg, Richard S

“…Insights into inflammatory bowel disease (IBD) are advancing rapidly owing to immunologic investigations of a plethora of animal models of intestinal…”
Get full text

Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4 by Junker, Yvonne, Zeissig, Sebastian, Kim, Seong-Jun, Barisani, Donatella, Wieser, Herbert, Leffler, Daniel A, Zevallos, Victor, Libermann, Towia A, Dillon, Simon, Freitag, Tobias L, Kelly, Ciaran P, Schuppan, Detlef

“…Ingestion of wheat, barley, or rye triggers small intestinal inflammation in patients with celiac disease. Specifically, the storage proteins of these cereals…”
Get full text